In 2010, he was named senior vice president, Global Commercialization, Oncology and Immunology, before becoming president of the company’s U.S. to assume the role of senior vice president, U.S. In 2004, he was appointed senior vice president, European Marketing and Brand Commercialization. He assumed added responsibility for Greece and Israel in 2001, and for South East Europe in 2003. Giovanni joined Bristol Myers Squibb in 2000 as vice president and general manager, Italy, in the Worldwide Medicines Group. This was preceded by his work as the company’s chief commercial officer. Prior to becoming CEO, Giovanni served as chief operating officer with responsibility for leading a fully integrated worldwide commercial organization and the companywide functions of Enterprise Services and Global Manufacturing & Supply. As a leader, he is focused on the business value of a company culture that promotes and rewards diversity and inclusion. With a background as a physician, Giovanni has helped strengthen the company’s patient-focused culture - one driven by innovation, speed, accountability and passion. Under his leadership, Bristol Myers Squibb is evolving its operating model, in order to increase speed and competitiveness. In May 2017, he assumed the role of chairman of the board.Īs CEO, Giovanni has led the company’s focus on researching and developing transformational medicines, which includes a leading portfolio of immunotherapies that are fundamentally changing the way cancer is treated.

Giovanni Caforio, MD, has been chief executive officer of Bristol Myers Squibb since May 2015 and has been serving on the company’s Board of Directors since June 2014.

Barry hansen fish heads